The table below shows Akari Therapeutics Plc's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
$367.88K
$607.68K
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$2.81M
$6.98M
$5.45M
$3.92M
$9.13M
$8.82M
SG&A
$9.28M
AKTX annual revenue (10-K history)
Akari Therapeutics Plc reported annual revenue of $367.88K for fiscal year 2023. That is down 39.5% from $607.68K in fiscal 2022. Figures come from the company's audited annual reports as filed with the SEC.